Single-Port and Multi-Port Laparoscopic Left Lateral Liver Sectionectomy for Treating Benign Liver Diseases: A Prospective, Randomized, Controlled Study

医学 端口(电路理论) 外科 随机对照试验 失血 腹腔镜检查 前瞻性队列研究 并发症 电气工程 工程类
作者
Minggen HuGuodong,ZhaoFei Wang,Dabin XuRong Liu
摘要

Background The use of single-port laparoscopy for leftlateral liver sectionectomy (LLLS) has been reported in the literature, but the effectiveness and safety of LLLS has not been validated in randomized, controlled trials. This prospective randomized controlled trial compared the effectiveness and safety of single-port and multi-port laparoscopic LLLS for the surgical treatment of benign liver disease. Methods Altogether, 38 patients aged 17–65 years (16 men, 22 women) with benign liver diseases were hospitalized for elective laparoscopic LLLS between January 2010 and December 2012. Patients were randomly assigned to either single-port (n = 19) or multi-port (n = 19) laparoscopic LLLS. Main outcome measures were operative time, volume of intraoperative blood loss, complication rates, and postoperative hospitalization. Results Baseline characteristics of the two groups were comparable. Single-port and multi-port laparoscopies were successfully completed in all but one patient (1/19, 5.3 %) who required conversion from a single-port to a multi-port procedure. The two groups had similar mean operative times and volumes of intraoperative blood loss. There were no clinically significant postoperative complications or deaths. The single-port group had a significantly shorter postoperative hospitalization than the multi-port group (2.5 ± 1.7 vs. 4.0 ± 2.1 days; p 0.05). Conclusions Single-port laparoscopic LLLS is a technically feasible, effective, safe alternative to multi-port laparoscopy for the treatment of benign liver diseases in cautiously selected patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyyyy完成签到,获得积分10
刚刚
刚刚
大侠发布了新的文献求助10
刚刚
魁梧的乐天完成签到,获得积分20
刚刚
冯度翩翩完成签到,获得积分10
1秒前
科研通AI2S应助satchzhao采纳,获得10
1秒前
jijizz完成签到,获得积分10
2秒前
一一发布了新的文献求助10
2秒前
小马甲应助ChiDaiOLD采纳,获得10
2秒前
2秒前
鳗鱼灵寒发布了新的文献求助10
3秒前
shatang发布了新的文献求助10
3秒前
lesyeuxdexx完成签到 ,获得积分10
5秒前
6秒前
程琳完成签到,获得积分20
7秒前
8秒前
卓哥发布了新的文献求助10
8秒前
科研通AI5应助sansan采纳,获得10
9秒前
9秒前
9秒前
脑洞疼应助杰森斯坦虎采纳,获得10
9秒前
11秒前
12秒前
研友_QQC完成签到,获得积分10
12秒前
NeuroWhite完成签到,获得积分10
12秒前
12秒前
搜索v完成签到,获得积分10
13秒前
liuchuck完成签到 ,获得积分10
13秒前
13秒前
13秒前
猫独秀完成签到,获得积分10
13秒前
15秒前
buno应助yuefeng采纳,获得10
15秒前
yiming完成签到,获得积分10
15秒前
落落发布了新的文献求助10
16秒前
清秋若月完成签到 ,获得积分10
16秒前
16秒前
呵呵呵呵完成签到,获得积分10
17秒前
17秒前
远方发布了新的文献求助10
18秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527928
求助须知:如何正确求助?哪些是违规求助? 3108040
关于积分的说明 9287614
捐赠科研通 2805836
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716904
科研通“疑难数据库(出版商)”最低求助积分说明 709808